Company Introduction

Tianjin Tasly Sants Pharmaceutical Co., Ltd. was founded on 30 October 2007. It is a joint venture invested by Tasly Group and Sants, one of the COOP’s subsidiaries. COOP is one of the most influential business groups in UK. The total investment is 280 million RMB.

The major business of Tianjin Tasly Sants Pharmaceutical Co., Ltd. includes research, development and production of medicines. The production capacity is expected to be 2.1 billion solid tablets and capsules, with all the products exported to European and American markets. The manufacturer will be designed according to EMEA, MHRA and FDA requirements and is planned to pass the cGMP certification. This will be the pharmaceutical factory to get the three certifications in China.

People are the most important asset of the company. we will provide you with attractive compensation and benefits system and a platform for you to give a full play of your talent and to grow together with the company.

公司简介

天津天士力圣特制药有限公司成立于2007年10月30日，是天士力集团与英国具影响力的企业集团之一的英国高品集团公司（COOP公司）旗下的子公司圣特公司（SANTS）共同投资建立的合资企业，投资总额两亿八千万元人民币。

天津天士力圣特制药有限公司的主要业务包括药品的研究、开发及生产，预计年产21亿片固体制剂，产品全部销往欧美市场。工厂将根据欧盟EMEA、英国MHRA和美国FDA要求进行设计并通过cGMP认证，这将是中国完成这三大全球性的认证的医药企业。

人才是公司宝贵的财富，我们将给您尽情施展自己才华的舞台，与公司一同成长！